[1]王巍东,王晶晶,李　闯,等.中年高血压患者阿司匹林抵抗及其相关危险因素分析[J].新乡医学院学报,2017,34(3):216-219.[doi:10.7683/xxyxyxb.2017.03.016]
　WANG Wei-dong,WANG Jing-jing,LI Chuang,et al.Risk factors analysis of aspirin resistance in middle-aged hypertensive patients[J].Journal of Xinxiang Medical University,2017,34(3):216-219.[doi:10.7683/xxyxyxb.2017.03.016]
点击复制

中年高血压患者阿司匹林抵抗及其相关危险因素分析
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
34
期数:
2017年3
页码:
216-219
栏目:
临床研究
出版日期:
2017-03-05

文章信息/Info

Title:
Risk factors analysis of aspirin resistance in middle-aged hypertensive patients
作者:
王巍东1; 2; 王晶晶3; 李　闯2; 贺立山1
（1.新乡医学院第一附属医院血液内科，河南　卫辉　453100；2.新乡医学院第三附属医院输血科，河南　新乡　453003；3.新乡医学院第一附属医院肿瘤科，河南　卫辉　453100）
Author(s):
WANG Wei-dong1; 2; WANG Jing-jing3; LI Chuang2; HE Li-shan1
（1.Department of Hematology，the First Affiliated Hospital of Xinxiang Medical University，Weihui 453100，Henan Province，China；2.Department of Transfusion，the Third Affiliated Hospital of Xinxiang Medical University，Xinxiang 453003，Henan Province，China；3.Department of Oncology，the First Affiliated Hospital of Xinxiang Medical University，Weihui 453100，Henan Province，China）
关键词:
中年高血压; 血栓弹力图仪; 阿司匹林抵抗; 阿司匹林敏感
Keywords:
middle-aged hypertension; thrombelastograph; aspirin resistance; aspirin sensitivity
分类号:
R544.1
DOI:
10.7683/xxyxyxb.2017.03.016
文献标志码:
A
摘要:
目的　探讨中年高血压患者发生阿司匹林抵抗的危险因素。方法　应用血栓弹力图测定2012年5月至2015年4月在新乡医学院第三附属医院就诊的中年高血压患者177例，根据是否发生阿司匹林抵抗分为阿司匹林抵抗组和阿司匹林敏感组，比较2组患者的一般临床资料。根据患者血压控制水平分为血压达标组（收缩压<140 mmHg，舒张压<90 mmHg，1 mmHg=0.133 kPa）和血压不达标组（收缩压≥140 mmHg或舒张压≥90 mmHg），比较2组患者阿司匹林抵抗发生率情况，并对中年高血压患者发生阿司匹林抵抗的危险因素进行logistic回归分析。结果　中年高血压患者177例中阿司匹林抵抗发生率为21.5%（38/177）。血压达标组患者阿司匹林抵抗发生率为 11.8%（10/85），血压不达标组患者阿司匹林抵抗发生率为30.4%（28/92），血压不达标组患者阿司匹林抵抗发生率显著高于血压达标组（χ2=8.978，P<0.05）。阿司匹林抵抗组患者体质量、空腹血糖均显著高于阿司匹林敏感组（P<0.05）；阿司匹林抵抗组较阿司匹林敏感组女性比例高（P<0.05）；logistic回归分析显示，空腹血糖、女性为阿司匹林抵抗的独立危险因素（P<0.05）。结论　中年高血压患者出现阿司匹林抵抗时，有较多的女性患者，阿司匹林抵抗的发生与患者空腹血糖和血压控制相关。
Abstract:
Objective　To evaluate the risk factors of aspirin resistance in middle-aged hypertensive patients.Methods　Thromboela-stogram （TEG） was used to identify the aspirin resistance in 177 middle-aged hypertensive patients in the Third Affiliated Hospital of Xinxiang Medical University from May 2012 to April 2015.The patients were divided into aspirin resistance group and aspirin sensitivity group according to whether or not the patients with aspirin resistance.All the patients were treated with aspirin for 10 days，then the inhibition ratio of platelet induced by arachidonic acid was determined.The clinical data of patients was compared between the two groups.The patients were divided into normal blood pressure group（systolic blood pressure <140 mmHg and diastolic blood pressure <90 mmHg，1 mmHg=0.133 kPa） and high blood pressure group （systolic blood pressure≥140 mmHg or diastolic blood pressure≥90 mmHg） according to the levels of blood pressure of the patients.The incidence of aspirin resistance was compared between the two groups，logistic regression analysis was used to analyze the risk factors of aspirin resistance in middle-aged hypertensive patients.Results　The incidence rate of aspirin resistance in middle-aged hypertensive patients was 21.5%（38/177）.The incidence rate of aspirin resistance was 11.8%（10/85），30.4%（28/92） in the normal blood pressure group and high blood pressure group respectively；the incidence of aspirin resistance in high blood pressure group was significantly higher than that in the normal blood pressure group（χ2=8.978，P<0.05）.The body weight，fasting blood glucose of patients in aspirin resistance group was significantly higher than that in the aspirin sensitivity group（P<0.05）.The number of female in aspirin resistance group was significantly higher than that in the aspirin sensitivity group（P<0.05）.Logistic regression analysis showed that fasting blood glucose，women was the independent risk factors for aspirin resistance （P<0.05）.Conclusion　Female middle-aged hypertensive patients are more likely to develop aspirin resistance.Aspirin resistance is associated with impaired fasting glucose and poor blood pressure control.

参考文献/References:

［1］　何清，李嫣然，吴方.厄贝沙坦与老年高血压患者血栓事件的相关性研究［J］.内科理论与实践，2016，11（3）：180-184.
［2］　PATRONO C.The multifaceted clinical readouts of platelet inhibition by low-dose aspirin［J］.J Am Coll Cardiol，2015，66（1）：74-85.
［3］　毛近隆，李晓宇，孙蓉.环氧合酶（COX-2）抑制剂提高心血管安全性的抗炎机制探讨［J］.中国中药杂志，2014，39（20）：4054-4059.
［4］　ERKAN L G，GUVENC G，ALTINBAS B，et al.The effects of centrally injected arachidonic acid on respiratory system：involvement of cyclooxygenase to thromboxane signaling pathway［J］.Respir Physiol Neurobiol，2016，225（1）：1-7.
［5］　LI Y B，HAN J Y，JIANG W，et al.Selenium inhibits high glucose-induced cyclooxygenase-2 and P-selectin expression in vascular endothelial cells［J］.Mol Biol Rep，2011，38（4）：2301-2306.
［6］　SON D J，AKIBA S，HONG J T，et al.Piperine inhibits the activities of platelet cytosolic phospholipase A2 and thromboxane A2 ynthase without affecting cyclooxygenase-1 activity：different mechanisms of action are involved the inhibition of platelet aggregation and macrophage inflammatory response［J］.Nutrients，2014，6（8）：3336-3352.
［7］　CAI G，ZHOU W，LU Y，et al.Aspirin resistance and other aspirin-related concerns［J］.Neurol Sci，2016，37（1）：181-189.
［8］　朱艳利，蒋绍博，卓晶明，等.中年高血压发病的危险因素分析［J］.山东医药，2013，53（31）：33-35.
［9］　王建铭，黄从新，袁早送，等.湖北省中年人群高血压的发生情况及危险因素分析［J］.广西医学，2015，37（12）：1718-1720.
［10］　中国高血压防治指南修订委员会.中国高血压防治指南2010［J］.中华心血管病杂志，2011，39（7）：585.
［11］　曹剑，范利，刘霖，等.血栓弹力图评价老年心血管病患者阿司匹林抵抗的发生率及危险因素［J］.中华老年心脑血管病杂志，2011，13（9）：790-793.
［12］　KAWASAKI T，OZEKI Y，LGAWA T，et al.lncreased platelet sensitivity to collage in individuals resistant to low-dose aspirin［J］.Stroke，2000，31（3）：591-595.
［13］　VALLES J，SANTOS M T，AZNAR J，et al.Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality：the effect of low-does is less than optimal in patients with vascular disease due to prothromhotic effects of erythrocytes on platelet reactivity ［J］.Circulation，1998，97（4）：350-355.
［14］　PATRONO C.Prevention of myocardial infarction and stroke by aspirin：different mechanisms different dosage［J］.Thromb Res，1998，92（1）：s7-s12.
［15］　TAYLOR D W，BARNETT H J，HAYNES R B，et al.Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy；a randomized controlled trial.ASA and Carotid Endarterectomy（ACE） trial collaborators［J］.Lancet，1999，353（9171）：2179-2184.
［16］　PAMUKU B.A review of aspirin resistance：definition，possible mechanism，detection with platelet function tests，and its clinical outcomes［J］.Thromb Thromboltsis，2007，23（3）：213-222.
［17］　OZBEN B，TANRIKULU M A，OZBEN T，et al.Aspirin resistance in hypertensive patients［J］.J Clin Hypertens，2010，12（9）：714-720.
［18］　朱宝琛，师帅，王欢，等.不同高血压等级代谢综合征患者的血栓形成特征［J］.新乡医学院学报，2016，33（7）：613-614，619.
［19］　GUM P A，KOTTKE-MARCHANT K，POGGIO E D，et al.Profile and prevalence of aspirin resistance in patients with cardiovascular disease［J］.Am Cardiol，2001，88（3）：230-235.
［20］　AHMED R M，MOUSTAFA M S，SHAWKY K M，et al.Obesity is it a major risk for developing aspirin resistance in old adults［J］.Am Geriater Soo，2012，60（1）：180-182.

更新日期/Last Update: 2017-03-05